ABBV-319 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since August 2026

Pipeline

Phase 1: 1

Top Sponsors

AbbVie1

Indications

Dry Eye Syndrome1
Systemic Lupus Erythematosus1
Lupus1
Arthritis1

Avon Park, Florida1 trial

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.